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1. Introduction 
Biofilms are microbial monoespecie or multispecie (consortium) communities that are the most 
successful colonization among microorganisms, are ubiquitous in nature and responsible for 
many diseases. They are considered growing communities of microorganisms embedded in a 
self-produced exopolysaccharide matrix and are attached to an inert surface or living tissue 
(Castrillón et al., 2010). 
It is believed that this organization represents the mode of cell growth that allows cells to 
survive in hostile environments, disperse to form new niches and gives them significant 
advantages in protection against environmental fluctuations such as humidity, temperature, 
pH, the concentration of nutrients and waste removal (Costerton et al., 1987, Hall-Stoodley 
et al., 2004). 
There is an association between the presence of biofilm-grown microorganisms with delayed 
wound healing and various diseases such as endocarditis, otitis media, chronic prostatitis, 
cystic fibrosis, periodontitis, and related infections medical devices and implants responsible 
for nosocomial infections (Castrillón et al., 2011, Donlan & Costerton, 2002). The latter share 
common features, although the causative organism and the site of infection are very different, 
they all evade host defenses and resist treatment with antimicrobials. In general, bacteria in 
biofilms tolerate high levels of antibiotics compared with planktonic cells (free). The ability of 
biofilm formation is not restricted to any specific group of bacteria or fungus and is now 
considered that under ideal conditions all microorganisms can form biofilms (Lasa et al., 2005). 
2. Stages of development of biofilms 
The main experimental models for studying bacterial biofilms are four: Escherichia coli, 
Psedomonas aeruginosa, Bacillus subtilis and Staphylococcus aureus (Lopez et al., 2010) and fungi 
Candida albicans and Aspergillus fumigatus (Kumamoto, 2002, Müller et al. 2011). In these 
works describes the development of a biofilm which begins with planktonic bacteria (free) 
that bind irreversibly to a surface in a continuous process in accordance with various stages 
of development are:, b) adhesion, c ) synthesis of extracellular matrix, d) maturation and e) 
dispersion, which leads to the formation of a uniform structure of deposits and 
accumulations of viscous and homogeneous material surrounding the cells by a polymer 
matrix with open channels for water movement (Figure 1). 
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Any natural or synthetic surface is covered by the constituents of the local environment, 
electrolytes, water and organic materials form a film before the arrival of the organism 
which neutralize the charge over the surface (conditioning) that prevents the aproximation 
between bacterial cells fungi and so begins adherence, these organic compounds can serve 
as nutrients for these microorganisms. 
Free (or planktonic) cells form a layer that is adsorbed to the surface for short periods by 
electrostatic attraction forces and released from it by reversible adsorption (Bos et al., 1999). 
In this phase the microorganisms are still susceptible to action of antibiotics. 
The microorganisms in suspension are aggregated and cell adhesion occurs with same or 
different cells (co-aggregation) to the surface conditioned, this process is favored by several 
bacterial components involved in this process by overcoming the repulsive forces such as 
pili or flagella, and surface polymers such as lipopolysaccharide in Gram-negative bacteria 
and mycolic acid in Gram-positive. The expression of these microbial structures may change 
depending on the environment in which they are and thus change the phase of biofilm 
formation. Mutants no-mobile fail to form monolayers and their union as microcolonies 
therefore mobility structures play an important role in the initiation of biofilm (Stickler, 
1999).  
The physicochemical properties of the surface can exert a strong influence on the degree and 
extention of adherence, the germs adhere more readily to hydrophobic surfaces, non-polarized 
and plastics such as Teflon, compared to hydrophilic metals such as glass or metal. 
Once irreversible adhesion is achieved, the cells divide and colonize the surface and when 
the local concentration of chemical signals produced by microbial metabolism reaches a 
threshold level, suggesting that the microbial population density has reached a minimum, 
this determines the start of phenotypic changes in the community. 
The process in which a microbial cell senses the proximity of other cells reaching a critical 
number in a limited space in the environment, chemical signals are generated corresponding 
to secondary metabolites, known as quorum sensing, this fact results in the autoinduction in 
the synthesis of the extracellular matrix or exopolysaccharide (composed of polysaccharides, 
proteins, nucleic acids and lipids), and thus gets to the maturation of biofilm formation with 
subsequent three-dimensional structure, generated by water channels that serve as the 
microcirculation in colonies. When the message is large enough, the organism responds like 
a mass and behaves as a group (Keller & Surette, 2006). The composition of the 
exopolysaccharide or glycocalyx is different for each bacteria and fungus, and varies 
depending on culture conditions, medium and substrates which are: alginate in P. 
aeruginosa, cellulose in S. typhimurium, rich in galactose in V. cholerae and poly-N-
acetylglucosamine in S. aureus (Whitehead et al., 2001, Sutherland 1997). This matrix allows 
the interconnection of immobilized cells and acts as a digestive system that keeps external 
extracellular enzymes close to the cells and enables them to metabolize biopolymers and 
colloidal solids (Sauer et al., 2002, Flemming & Wingender, 2010). 
The detachment may be seen as another stage of the life cycle of the biofilm, which can be 
reached or not depending on environmental conditions such as nutrient availability, 
oxygenation, pH and specific compounds because at some point the high density cell can 
result in severe, dynamic gradients of nutrients and toxic metabolic sub-products, then some 
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cells are released from the matrix to colonize other surfaces closing the process of formation 
and development of biofilms, this process may be the result of several factors such as are: 
mechanical forces as the flow of blood vessel, cessation of production of exopolysaccharides 
and detachment factors such as enzymes that destroy the matrix or surfactants.  
Fragments of biofilm with viable cells can be dispersed in liquids or aerosols. The scattering 
process is of interest for their potential to promote the spread of bacteria or fungi in the 
ambient or their ability to exploit these processes to combat infections (Hall-Stoodley & 
Stoodley, 2005). 
For the development cycle of Candida albicans biofilms has shown that scattered cells show a 
distinct phenotype associated with increased virulence (Uppuluri et al., 2010). When the 
extracellular medium accumulates enough of these molecules activate specific receptors that 
alter gene expression and affect different phenotypes that produce virulence factors such as 
enzymes and toxins or rhamnolipid of P. aeruginosa cell that are protective of fagocytosis, 
the quorum sensing determines tolerance to antibiotics and innate inflammatory response 
dependent on polymorphonuclear cells. 
 
Biofilm formation occurs as a series of sequential events that depend on the interaction of microorganisms 
on inert surfaces or living, by overcoming the repulsive forces to achieve irreversible adsorption followed 
by the formation of a microcolony. Upon reaching a certain population density, induce the synthesis of 
secondary metabolites (quorum sensing) that produces an exopolysaccharide formation until maturation of 
the biofilm. Disintegration allows the formation of a new colony or elimination. It shows the treatment 
options for different stages of biofilm development. 
Fig. 1. Phases of biofilm formation and dispersal strategies. 
The main characteristic that best distinguishes chronic infections associated with biofilm to 
acute infections is their response to treatment with antibiotics, in general biofilm 
microorganisms tolerate high levels of antibiotics compared to planktonic cells and cause 
recurrent episodes. In the case of acute infections these are eliminated after a short 
treatment. In addition, acute infections are more aggressive than those associated with 
chronic infections or implants as the latter persist for months or years and progress through 
periods of rest alternating with exacerbations. 
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3. Host resistance to biofilm 
Biofilms cause chronic infections characterized by persistent inflammation and tissue 
damage despite treatment with antibiotics and innate and adaptive immune responses of 
the host. 
Planktonic cells that are released directly from the biofilm was removed by the action of 
antibiotics and phagocytic cells activated, but the organization as a biofilm is considered as a 
very efficient defensive strategy adopted since these microorganisms grow slowly and are 
protected mechanisms of host resistance through various strategies among which are a) 
inability of antibodies, complement and lysozyme to penetrate these organizations 
multicellular b) production of catalase bacteria that prevents the action of hydrogen 
peroxide produced by oxidative mechanisms of phagocytic cells c ) inhibition of host 
immune function such as chemotaxis, opsonization and bactericidal potential 
exopolysaccharide (Lasa et al., 2005). 
A study has demonstrated inability of the immune system clearance sessile cells that persist 
for weeks and months was observed when the peritoneal cavity of rabbits were inoculated 
mature biofilms of P. aeruginosa in immunocompetent animals, the penetration of phagocytic 
cells in the biofilm was detected, however, these cells were unable to phagocytose the 
bacteria (Ward et al., 1992). A similar response was described with the inoculation of 
fragments of the same biofilm bacteria trapped in agar beads and introduced into the lung 
(Woods et al., 1980). 
4. Identification tests and antibiotic susceptibility in biofilms 
In clinical samples, a biofilm is difficult to detect in routine diagnosis but may be recognized 
by light microscopy and accurate identification of bacteria in a biofilm can only be done by 
techniques of hybridization, fluorescein staining, the molecular probe 16SRNA domain 
eubacteria (EUB 338), determining live cell / dead BacLight staining or by identifying the 
matrix components by specialized staining techniques (Veeh et al., 2003). 
Routine microbial cultures provide misleading results because they do not reflect the 
increasing resistance of bacteria growing in biofilms. The minimum inhibitory concentration 
(MIC) of bacteria grown as biofilm is 100 to 1000 times higher compared to planktonic cells 
despite antibiotic susceptibility in the laboratory (Costerton et al., 1999). 
There are no standardized methods to date used routinely to determine the antibiotic 
sensitivity of bacteria grown as biofilms. When sampling swab and plating growth obtained 
in cultures performed standardized susceptibility testing, these same antibiotics fail to solve 
conventional bacterial infections This is because bacteria grow attached and the surface as a 
biofilm. However, in many cases it is not possible to recover the bacteria by traditional 
culture methods. This has been reported in infections where Staphyococcus biofilms 
emerging vascular grafts stimulate the production of antibodies against biofilms initiated 
within 10 days of colonization, however, cells were never recovered by conventional 
techniques of microbial culture (Costerton al ., 2003), another case is related to infections in 
medical devices where antibiograms shown susceptibility against some microorganisms but 
the infection fails to be eliminated by these antibiotics (Fux et al., 2005). 
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It is very important to point out that the systems sensitivity to antibiotics were traditionally 
performed on cells in suspension, which is equivalent to the population of planktonic cells, 
for this reason, is necessary to design new laboratory techniques that reveal the sensitivity of 
these substances directly on biofilms, this idea has been reported that antibiotics active 
against stationary phase bacteria in vitro are successful in removing biofilms in vitro 
infections (Zimmerli et al., 1998). 
This information is important to consider that when it is mentioned that biofilm infection 
has hematogenous dissemination must specify if they are planktonic cells or biofilm 
fragments because there are differences in their ability to resist antibiotics, adherence and 
host response resistance. 
5. Horizontal gene transfer 
Mobile elements such as plasmids and transposons, have proven important in the transfer of 
antibiotic resistance is enhanced when the cell density increases and competition genetic, 
hence that biofilms are an ideal state to promote the horizontal transfer of genes (Ghigo, 
2001). However, there is evidence that when bacteria of a biofilm is dispersed is rapidly 
becoming susceptible so their resistance is not the result of mutations and mobile elements 
(Stewart & Costerton, 2001, Stewart, 2002). 
Increasing resistance to beta-lactams, aminoglycosides and fluoroquinolones has been 
correlated to the frequency of mutations in bacteria that grow as biofilms (Hoiby et al., 
2010). These facts lead to rapid and global spread of genes in natural environments and in 
hospitals favoring nosocomial infections associated with biofilms. 
6. Mechanisms of resistance associated with biofilms 
The conventional mechanisms of resistance to antibiotics and biocides fall into four 
categories: direct inactivation of the active molecule, altering the body's sensitivity by 
changing its target of action, reducing the concentration of the drug reaches its target 
unchanged its chemical composition and efflux systems (Hogan & Kolter, 2002, Poole 2002). 
However, most information comes from studies that were performed in suspension cultures 
and in general, bacteria in biofilms tolerate high levels of antibiotics compared to what their 
planktonic cells. In different settings, the level of antibiotic resistance may vary and the 
factors causing this increase may differ. 
The primary evidence indicates that conventional mechanisms do not explain the high 
resistance to antimicrobial agents associated with biofilms, although this evidence does not 
exclude the possibility of resistance in the growth of adherent cells. This suggests that the 
development of resistance in bacteria that are aggregated on surfaces or biofilm has its own 
intrinsic mechanisms are different and are responsible for those conventional antibiotic 
resistance, and although currently no single accepted mechanism, we have explored several 
potential candidates as responsible for this high resistance characteristic of biofilms among 
which are: Diffusion limited, neutralizing enzymatic, functional heterogeneity, slow growth, 
persistent cells and biofilm phenotype corresponding to adaptive mechanisms to stress such 
as efflux pumps and alterations in membrane. (Figure 2). 
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The antibiotic may be retained by interactions with the extracellular matrix or be neutralized by the 
production of enzymes that modify it. The metabolic heterogeneity may alter the growth preventing 
antibiotic action if its molecular target requires active metabolic pathways, or the oxygenation or pH 
gradients inhibit the action of the antimicrobial. The appearance of persistent or phenotype within 
biofilm makes it insensitive to the antibiotic 
Fig. 2. Antibiotic resistance associate to biofilms. 
6.1 Low penetration 
Antibiotics can diffuse through the biofilm matrix, to inactivate the cells trapped, but this 
exopolysaccharide behaves as a physical barrier affecting its spread to deeper layers by 
direct interaction of these molecules to modify their transport to the interior, causes 
resistance to these antimicrobials, as well as high molecular weight molecules with cytotoxic 
properties as lysozyme and complement. So, while planktonic cells are quickly exposed to 
high concentrations of antibiotics, the microorganisms in deep layers are gradually exposed 
to increasing the concentration of antibiotics. 
Bacteria that are deficient in polysaccharide synthesis and therefore of produce biofilm, 
escape from the biofilm and are susceptible to attack by immunocompetent cells. An 
antibiotic may be inactivated or sequestered by binding to the extracellular matrix as in the 
case of the alginate exopolysaccharide of P. aeruginosa which is anionic nature. Which 
explains why the fluoroquinolones and aminoglycosides penetrate slowly rapidly since the 
latter positively charged bind to the matrix has a negative charge, but this mechanism can be 
saturated if repeated doses are administrated (Lewis, 2001, Gordon et al. , 1988, Mah & 
O'Toole, 2001). 
The penetration of chlorine does not reach concentrations greater than 20% in mixed 
cultures of K. pneumoniae and P. aeruginosa biofilms. In case of biofilms of S. epidermidis 
vancomycin reaches deep layers but not rifampin (Mah & O'Toole, 2001). 
Has also been observed that the thickness of the biofilm is important for the penetration of 
hydrogen peroxide was allowed in layers with 3.5 log CFU P. aeuroginosa and not diffusion 
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when the layer was 7.6 log CFU, however, the absence of catalase gene (kata) makes it easy 
access even if the biofilm is thick (Stewart et al., 2000). 
The dissemination and death from alkaline hypochlorite (pH 11) and chlorosulphamate (pH 
5.5) was evaluated on biofilms of P. aeruginosa. The chlorosulfamate transport was not 
affected unlike hypochlorite delaying their penetration, however both biocides enter to the 
biofilm and fail to kill cells suggesting an alternative mechanism to explain the resistance to 
these substances (Stewart et al., 2001). 
Other explanations for the failure to altering the penetration of antimicrobial agents in 
biofilms K. pneumoniae are that the cells are stacked or is the result of problems of 
bioavailability of the drug (Smith, 2005). 
Reduced mobility of an antibiotic is not an impenetrable barrier and is not sufficient to 
explain the resistance, it is assumed that other mechanisms must be involved. Recently it has 
been suggested that the delay in permeability through the biofilm allows the bacteria have 
enough time to implement adaptive responses to stress. 
6.2 Neutralization 
If an antibiotic penetrates the biofilm enzyme production by microorganisms can degrade or 
modify are synthesized by enzymes that selectively destroy the activity of antibiotics. These 
enzymes are a series of proteins that use multiple adaptive strategies to confer resistance such 
as hydrolysis (-lactams, macrolide esterases epoxidase) and modification of antibiotics by 
acyltransferases, phosphorylation, glycosylation, nucleotidilación, ribosylation and transfer of 
thiol groups (Wright, 2005, Castrillón et al., 2003, Gallant et al., 2005, Martinez-Suarez et al., 
1985). These enzymes accumulate in the glycocalyx as a result of its secretion or cell lysis (by 
action of the antibiotic on the microorganisms from the biofilm surface or planktonic). 
Neutralization acts synergistically with delayed diffusion and degradation of the 
antimicrobial into the biofilm. An important mechanism of resistance in cystic fibrosis by P. 
aeruginosa is due to the overproduction of cephalosporinase AmpC enzymes which is its 
main mechanism of resistance to beta lactam in the presence of high levels of carbapenems 
such as imipenem which is a strong inducer in contrast with ceftazidime is weak probably 
due to its inactivation in the biofilm (Del Valle, 2009, Giwercman, 1991 ). 
The filters impregnated with antibiotics and its direct action on biofilms K. pneumoniae has 
shown that the antibiotic diffuses only in the presence of mutant cells -lactamases but 
growth is observed, suggesting that another mechanism of resistance must be considered 
(Anderl et al., 2000). 
6.3 Heterogeneity  
To determine the rate of microbial growth within a biofilm microelectrodes were used with 
probes for direct measurement of oxygen in different areas of the biofilm, and the use of 
acridine orange to identify fast-growing cells (stained orange) or slow (stained yellow/ 
green) according to their relative concentration of RNA / DNA. (Mah & O¨Toole 2001). 
These studies demonstrate that biofilms are structurally and metabolically heterogeneous in 
which aerobic and anaerobic processes occur simultaneously and display areas so that 
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metabolically inactive antimicrobial response may vary depending on the location of an 
individual cell within the community and that the high level of activity on the surface and 
limited or absent growth inside reduces the susceptibility to antibiotics. 
These studies have shown that biofilms are heterogeneous structures with three chemical 
patterns that correspond to differences in concentration gradients from outside to inside the 
biofilm. The pattern of metabolic substrate induces a higher concentration on the outside 
and less inside, the metabolic product pattern is reversed to the previous and the pattern of 
metabolic intermediates shows a greater concentration between the boundary of the biofilm 
in the aqueous phase (Stewart & Franklin , 2008). These patterns bring the result that within 
these structures are established differences in pH gradients and oxygenation as it has been 
shown that the penetration of oxygen as high as 25% in the depth of the biofilm (Borriello et 
al., 2004). These facts are installed microbial populations aerobic or facultative anaerobes 
within the different layers of the biofilm, allowing us to understand the differences in 
susceptibility to treatment with antibiotics, which is different from the response to the free 
forms (plankton) that the attached (sessile). 
Deprivation of oxygen and anaerobic growth of microorganisms affects the action of 
aminoglycosides which is modulated by the availability of oxygen and pH gradients 
(Wimpenny, 2000). 
6.4 Slow growth 
When an organism is limited nutrients, slow growing and may cause resistance to 
antibiotics. Cells within biofilms are under a gradient of nutrients resulting in metabolically 
active cells with access to these nutrients in the surface layer or on the periphery of the 
biofilm, in contrast, metabolically inactive cells are found within its interior. These different 
areas of metabolic activity correspond to different areas of antimicrobial susceptibility 
The decrease in growth rate and low metabolic activities decrease the cell permeability and 
therefore the access of antimicrobial substances, metabolic inactivity can also reach a level 
where the bacteria are viable but have lost their ability to be cultivated this state of non-
culturable viable cells is the main reason for the low detection of biofilm infections by 
standardized culture methods. 
The cytotoxic action of many antibiotics is dependent on the growth of microorganisms such 
as penicillins that are active are active only in growing cells, many antibiotics are targeting 
some kind of molecular synthesis and have no effect on bacteria where this synthesis has 
stopped, and cells in the interior might be protected from the cytotoxic action of these 
substances (Brown and Allison, 1988). Penicillin and ampicillin do not attack cells that are 
not growing and its action is proportional to its activity, other antibiotics such as -lactams, 
cephalosporins, aminoglycosides and fluoroquinolones attack stationary phase cells, but are 
more active in dividing cells (Costerton et al., 1999). It has been determined resistance to 
cetrimide on E. coli, ciprofloxacin on S. epidermidis, tobramycin and piperacillin in P. 
aeruginosa, this effect is associated with decrease in growth rate (Donlan & Costerton, 2002). 
Antimicrobial peptides are natural products produced as part of the arsenal of protection in 
the host innate responses and target microbial membrane (Castrillón et al., 2007). Colestine 
peptide (polymyxin E) has been used in the treatment of multidrug-resistant cancer patients 
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and cystic fibrosis by P. aeruginosa (Hachem et al., 2007), this antibiotic is the only 
antimicrobial activity against the central part of biofilms in vitro, while the metabolically 
active at the surface become tolerant due to the regulation system pmr operon genes and the 
MexAB-OprM. Ciprofloxacin and tetracycline are able to clear metabolically active cells so it 
is suggested that combination therapy with these antibiotics colistin for early eradication of 
P. aeruginosa in patients with cystic fibrosis (Pamp et al., 2008).  
6.5 Persistent cells 
A small percentage of the cell population remains viable after prolonged exposure (or 
overdoses) to antibiotics known as persistent, and gives (or not) their resistance to progeny 
once the selective pressure is removed. This susceptibility to the threshold of growth varies 
depending on the mode of action of antibiotic used. 
Persistent cells are cells that temporarily quit the replication for the survival of the community 
and their strategy is different from the stress-related adaptive responses in which the 
population expresses resistance proteins in response to potential environmental damage. 
Persistent cells survive doses of antibiotics that kill normal cells and increase in number when 
there is a high cell density reached the highest number in the stationary phase suggesting that 
their main role is to ensure the survival of cells that are not growing (Lewis 2008). 
These cells are different from the antibiotic-resistant mutants do not produce offspring 
resistant to the antibiotic in his absence and can grow in the presence of the antibiotic while 
maintaining the same minimum inhibitory concentration (MIC) in contrast to the mutants. 
The main evidence of the existence of persistent cells in biofilms are: a) there is a biphasic 
dimension in biofilms wich means that much of the population is attacked fast and another 
is not affected even with a prolonged course of antibiotics, b) description of gene of 
persistence (hip) that act as regulatory circuits that allow them to enter and leave this state as 
a protective response, c) bacteriostatic antibiotics inhibit the growth of sensitive cells are 
those that contribute to persistent cell growth and preservation of biofilm d) when therapy 
is withdrawn biofilm again reshape (Herrera 2004). 
The production of persistent cells in biofilms in bacteria is highest during the stationary 
phase in planktonic culture of the biofilm, however, in the case of Candida albicans their 
formation occurs only when growth occurs as a biofilm (Spoering & Lewis, 2001 ). 
Although the date is unknown the basics of the physiology of these persistent cells, several 
genes involved has been described for their generation, including locus have identified three 
hip (high-level-persistence): A, B and AB control the frequency of this phenotype. The 
identification of genes and their products may be targets for developing new therapies 
(Keren et al., 2004). 
All hip mutant cells produce a thousand times more cells persistent than the wild variant 
(Moyed & Broderick 1986). The importance of the appearance of these cells determines the 
success of treatment with antimicrobial use as the minimum bactericidal concentration 
would kill 99.9% of cells in biofilms, and the remaining would be eliminated by the immune 
system, without however, the presence of persistent cells limits the removal of the 
population of microbial cells or in the case of a dysfunction in the patient's immune 
response may be the cause of recurrent infections. 
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6.6 Biofilm phenotype 
Nutritional starvation and high cell density in a limited space are important features in in 
the physiology of planktonic cultures reaching stationary phase. Hence the formation of a 
biofilm represents this natural phase of bacterial growth by increasing production of 
secondary metabolites such as antibiotics, pigments and other molecules, which act as 
signaling molecules to form (or inhibition of growth of other microorganisms) of biofilms 
(Lopez et al., 2010). 
The response to environmental stresses such as heat shock, pH changes, oxygen and 
chemicals among others, cause physiological changes that act as protective antagonizing the 
harmful effects by inducing protective mechanisms such as efflux pumps of antibiotics, 
changes membrane level or phase variation. 
In biofilms in response to treatment with antibiotics, appear subpopulations with different 
phenotypes that vary in their gene expression but not in their genetic material (Fux et al, 
2005). This was confirmed when performing subcultures in fresh medium in which not only 
provide nutrients but also dilutes the cell-cell signaling, the cells regain susceptibility to the 
antibiotic, demonstrating the absence of mutations. 
The gene expression patterns in biofilms of P. aeruginosa produce different phenotypes that 
differ from their planktonic counterparts (Sauer et al., 2002) and a small proportion of cells 
develop a protective phenotype that coexists with the cells sensitive to antibiotics and has 
been suggested by some authors that corresponds to that expressed by a spore (Stewart & 
Costerton, 2001). 
A biofilm community that shows resistance to treatment by antibiotics and develops a 
characteristic phenotype such as biofilm growth has been called "biofilm phenotype" and have 
come to propose the existence of specific genes and reference to their therapeutic targets, 
however , DNA microarrays and gene expression in Bacillus subtilis biofilms differ only 6% 
compared to their planktonic cells and only 1% in Pseudomonas aeruginosa. At present, the 
differential expression of these genes has not proven useful for this purpose (Fux et al., 2005). 
6.6.1 Efflux pumps 
Accumulation of antibiotics in the periplasmic space inside the bacteria is antagonized by 
efflux pumps that are resistant to several classes of antibiotics including tetracyclines, 
macrolides, fluoroquinolones, -lactam and reducing their concentration at sub-toxic level 
(Van Bambeke et al ., 2003). 
Efflux pumps are protein structures that are able to expel from the bacterial cytoplasm and 
periplasm for bacteria toxic compounds such as antibiotics. The expression of these pumps can 
be permanent (constitutive expression) or intermittent (expression can be induced). These 
pumps may be specific to a substrate or similar compounds can be transported and may be 
associated with multidrug resistance (MDR). (Sánchez-Suarez et al., 2006, Grkovic et al., 2002). 
In prokaryotes there are five families of efflux transporters: MF (major facilitator), MATE 
(multidrug and toxic efflux), RND (resistance-nodulation-division), SMR (small multidrug 
resistance) and ABC (ATP binding cassette). All of them require proton motive power and 
power supply. 
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The main systems reported in bacteria of interest in the clinic are: Campylobacter jejuni 
(CmeABC), E. coli (AcrAB-TolC, TolC-AcrEF, EmrB, EmrD), Pseudomonas aeruginosa 
(MexXY-OprM, MexCD-OprJ, and OprN MexEF Mex-XY-OprM), Streptococcus pneumoniae 
(PmrA), Salmonella typhimurium (AcrB) and Staphylococcus aureus (NorA) and Candida 
albicans (MRD1, CDR1 and CDR2) (Webber & Piddock, 2003). 
It has been speculated the possibility of antibiotic resistance in biofilms of P. aeruginosa by 
the expression (or overexpression) of these pumps, however, none of the four efflux pumps 
in the genome of this bacterium contributes to the resistance (De Kievit et al., 2001). In 
contrast to these results, resistance to azithromycin is associated pumps MexAB-OprM and 
MexCD-OprJ to biofilm resistance mechanisms in P. aeruginosa (Gillis et al., 2005) and 
PA1874-1887 pump that is expressed at high level in both biofilms and planktonic cells 
(Zhang & Mah, 2008). Although the results are still inconclusive, have proposed the use of 
anti-inhibitor drugs efflux pumps (EPI) as potential anti-biofilm treatment have been well 
tolerated in humans (Kvist et al., 2008). 
When cells bind to a surface, expressed a different phenotype to the planktonic cells and 
may be expressed as a resistance mechanism multidrug efflux pump as reported in 
Escherichia coli (AcrAB operon mar). When mar expression was evaluated in a bioreactor and 
as growth in biofilm, the results support the idea that mar operon was expressed in biofilms 
where the lowest level was detected compared with the equivalent in stationary phase 
fermenter cultures (Maira Litrán et al., 2000a). The loss of acrAB mar did not affect the 
growth as biofilms of E. coli and resistance to ciprofloxacin is not dependent on the 
regulation of mar operons or acrAB (Maira Litrán et al., 2000b). 
In the case of Candida albicans pumps for azoles was noted that in mutants cdr planktonic 
cells and mdr were hypersusceptible to fluconazole in contrast to cells that were resistant 
biofilm showing that resistance is a complex phenomenon that can not be explained by a 
single mechanism (Ramage et al., 2002). 
6.6.2 Alterations in membrane proteins 
The diffusion of any antibiotic depends on the permeability of its outer membrane that 
allows its diffusion of different routes to the periplasmic space. Porins are channel proteins 
of the outer membrane of Gram-negative bacteria involved in the transport of hydrophilic 
molecules from the external environment to the periplasmic space. 
The genes encoding porins can mutate and produce nonfunctional or altered proteins can 
decrease their expression. Both processes give rise to mutant bacteria deficient in porins, 
which have low permeability to hydrophobic molecules pass (Hancock, 1997). 
A quick change of balance in the expression of porins in response to antibiotic therapy 
confers an advantage to the pathogen compared with the commensal microflora that is 
susceptible to lactams (Pagés et al., 2008). In the case of P. aeruginosa porin OprD is used 
for the dissemination of imipenem and resistance is associated with its three-dimensional 
disturbance. 
Porins in E. coli are OmpF and OmpC operated in response to changes in osmolarity. 
Mutations in ompB (regulator of OmpF and OmpC) increase resistance to -lactam 
antibiotics, the mutants lacking OmpF are resistant to chloramphenicol and tetracycline. 
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The genes encoding porins are differentially expressed in biofilms and may contribute to 
antibiotic resistance. The expression of ompC and three other osmotically regulated genes 
are increased when the bacteria grow as biofilms in the environment a protective 
mechanism (Mah & O'Toole 2001). 
6.6.3 Phase variation 
In biofilm there is capacity development of subpopulations of bacteria or fungi to switch to 
the dormant metabolic state as small-colony known variants (SCVs) in which they are less 
susceptible to growth-dependent antibiotic killing, have a defective catalase activity 
interfere with oxidative metabolism and uptake of aminoglycoside modifying its minimum 
inhibitory concentration of 8 to 16 times compared with large colonies and normal as in the 
case of Enterobacter aerogenes (Neut et al., 2007, Rusthoven al., 1979). 
The phase variation plays an integral role in the formation of diverse phenotypes within 
biofilms and is largely responsible for the recalcitrance of infections caused by biofilms, the 
increase in the reversal phase coincides with the antibiotic treatment. This phenomenon has 
been reported for several genera and species, including Staphylococcus and Pseudomonas 
genus, and certain species of Enterobacteriaceae and fungi. (Costerton et al., 1999).  
The phase variation causes detectable changes in colonial morphology, the small colony 
variants of phase variant (SCVs) in biofilms develop properties hyperadherence, 
autoaggregation, increased hydrophobicity and reduced motility, it has been suggested that 
tolerate a wide variety of aggressive environmental conditions so that this process is 
considered a survival mechanism. 
It was considered that the phase variation is a process of cellular internal rearrangement, 
however recently it has been considered to occur by interactions with genetic elements 
outside the cell as an internal bacteriophage genetic rearrangement by suggesting a model 
where mobile genetic elements generate the phase variation through a collective mechanism 
(Chia et al., 2008). 
In Pseudomonas aeruginosa has shown that under different environmental pressures will 
favor the appearance of morphological variants that relate to the phenotype of biofilm 
among which are the small-colony variants (SCVs), rough small-colony variant (RSCVs), 
wrinkled variants, and rugose colonies autoaggregating cells. The phenotypes RSCVs and 
SCVs play a critical role in the colonization in cystic fibrosis and mutations in the psl locus in 
variants RSCVs lose their hyperadherence and autoaggregation abilities ( Häubler et al, 
2003, Kirisits et al., 2005). 
The SCVs of S. aureus differ from normal phenotype in size as they are ten times smaller 
than the wild colonies and are deficient in electron transport by auxotrophism to hemin / 
menadione, thiamine or thymidine. Their colonies are non-pigmented on agar plates and 
reduced coagulase production increases resistance to aminoglycosides and cell-wall active 
antibiotics. The specific role of the SCVs of S. aureus resistance to antibiotics in biofilms is 
still unknown (Proctor & Peters, 1998) although its presence in mixed biofilms with 
Pseudomonas has proven to be a survival mechanism against the attack of the exotoxins of 
Pseudomonas for which its wild form is sensitive (Biswas et al., 2009). 
In staphylococcal biofilm formation requires intercellular adhesin (PIA) is a polymer whose 
main component is N-acetylglucosamine and is synthesized by several enzymes encoded by 
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intercellular adhesion cluster (ica), the presence of these genes correlated with the 
morphology colonial and the ability to form biofilms, so the net growth in Congo red agar 
form black colonies when the adhesin is present and red in its absence (Ziebuhr et al., 1997). 
The ica operon is constituted by a group of four structural genes icaA, icaB, icaC and a 
regulatory component icaR (Diemond & Miranda, 2007). Adhesin negative mutants do not 
produce biofilms due to an IS256 transposon in the gene icaC (Cho et al., 2002). 
It has recently been reported in strains of methicillin resistant Staphylococcus aureus (MRSA) 
that the presence of ica locus does not guarantee that its expression and does not directly 
reflect the ability of biofilm formation. Has been evaluated the participation of three regulatory 
genes agr and sarA and as well as the alternative transcription sigma factor sigB latter being 
responsible for the variation of biofilm (Jong-Hyun et al., 2008, Eftekhar & Dadaei T, 2011). 
In S. pneumoniae have described two variants of colonial morphology between colonies 
spontaneously switched between transparent and opaque, the latter capable of forming two 
to six times the capsule, with limited bonding capacity and the possibility of evasion of host 
immune system, this variation observed both in planktonic growth conditions and in 
biofilm. Other variants described in aged biofilms are small and not mucoid without capsule 
(SCVs) with capacity to form hyperadherent biofilms, in contrast to the large and mucoid 
variants that appear late in the biofilm adhere poorly to surfaces forming flat structures 
unable to form biofilms. The SCVs of S. pneumoniae correlated with reduced capsule 
production and an increase in initial attachment instead to the opaque and transparent 
colonies, the SCV non capsule cells are not reversible due to a deletion in the capsule operon 
cps3DSU (Allegrucci & Sauer, 2007). 
In Candida parapsilosis was previously thought that it was not able to form true filaments and 
biofilms, we now know they are not as large as those of Candida albicans and concentric 
phenotype forms quantitatively more biofilm in contrast to the smooth phenotype as it does 
in lesser extent and does not invade the agar (Laffey & Butler, 2005). 
The coexistence of microorganisms in biofilms may lead to the emergence of phenotypic 
variants as in the case of Pseudomonas putida and Acinetobacter strain C6 where the excretion 
of benzoate by Acinetobacter as a result of the metabolism of benzyl alcohol, induces phase 
variation in Pseudomonas as rough colony (Kirkelund et al., 2007). 
The importance of knowledge and isolation of these slow-growing variants (SCVs) are often 
misdiagnosed by routine microbiological analysis due to its unusual morphology and 
biochemical reactions which complicates eradication by failures in the antibiotic treatment 
7. Biofilm control 
Biofilms can be reformed if: a) there is growth of fragments, followed by debridement and 
cleaning, b) planktonic bacteria is spread, released from the biofilm residual, c) there is new 
growth of microorganisms in the biofilm (Cooper & Okhiria, 2010) . 
Antibiofilms actions can be divided in two: 1) Prevention of formation. and 2) removal or 
destruction of biofilms. Among the prevention strategies for catheter-related infections that 
have developed protocols aqre aseptic filtered air in operating rooms which has reduced the 
incidence of these infections and are based on the correct implementation of the measures of 
asepsis during insertion and maintenance of vascular pathways. The formation and training 
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of staff on the recommendations of the indication, insertion and maintenance of 
intravascular devices are the backbone of the prevention of catheter-associated infections. 
The methods for controlling biofilms are basically: prevent adhesion (material handling, use 
of antibiotics or anticoagulants) to prevent bacterial differentiation and congregation 
(quorum sensing antagonists or use of lactoferrin), matrix elimination (enzymes) and 
recently the administration of specific bacteriophages (Figure 1). 
Many of catheter-related infections due to microorganisms present in the skin are acquired 
when the catheters are inserted so that alternative strategies anti-colonization are being 
explored. Other alternatives would be to coat catheters or medical devices with antimicrobial 
agents (antibiotics, antiseptics and silver) incorporated into the implant material, with limited 
success. This is due to several reasons among which are the fact that biofilm infections are 
chronic and the half-life of these substances is shorter on the other hand the incorporation of 
these drugs can damage the implanted material or incompatibility with the host. 
The coating of catheters with antibiotics or biocides such as rifampin and minocycline or 
cefazolin, chlorex, silver sulfadiazine and silver impregnation decreases the possibility of 
colonization, has also proved successful when the catheter is used for short periods and as a 
prophylactic measure, but counterproductive in the long term the huge problem of 
resistance (Lewis, 2001, Raad & Hanna, 1999). 
The coating material with enzymes may be another option to prevent infections resulting 
from medical devices, recently reported peroxidase titanium coating which can generate 
antimicrobial hypothiocyanite hypoiodite or to form hydrogen peroxide or thiocyanate. This 
coated material and a liquid environment with substrates of the enzyme has been shown to 
limit the formation of biofilms of Candida albicans (Ahariz & Courtois, 2010). 
Recently have proposed new alternatives for delivery of antibiotics into the biofilm with the 
use of liposomes or biodegradable complexes that allow the drug concentration at the 
interfaces of the biofilm (Smith, 2005). 
The discovery of bacterial communication systems (quorum sensing) as a temporary facility 
during the infectious process has given an opportunity to decrease the bacterial infection by 
means other than growth inhibition. Because many bacteria use this communication system 
and control of virulence, quorum sensing mediators are the new targets for drug design 
(Hentzer & Givskov, 2003). These substances are known as quorum sensing inhibitors (QSI), 
which have been identified in nature and analogs have been synthesized by modifying its 
structure and assessed its activity in experimental systems in vivo and in vitro. QSI resistance 
occurs only in bacterial mutations. 
In the case of gram-negative bacteria depends on the communication mechanism of the 
synthesis of N-acyl homoserinlactones (AHL), so they have developed analogs of this 
substance that are aimed at inhibiting biofilm formation by several mechanisms: a) 
inhibition of AHL signal generation, b) inhibiting the spread of the intracellular signal and 
c) inhibiting the reception of AHL. In Gram-positive bacteria that use peptides as signaling 
molecules of quorum sensing. A synthetic peptide called RIP interferes with the reception of 
these signals in Staphylococcus aureus, is active in its ability to inhibit biofilm formation in 
animal models (Balaban et al., 2007). 
Substances that interfere in the formation of exopolysaccharide as xylitol and gallium have 
been used in formulations of oral biofilms management and iron chelating agents such as 
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lactoferrin, deferoxamine and EDTA are candidates for use in controlling biofilms. Recently 
it was shown that lactoferrin, a ubiquitous and abundant substance in secretions, stimulates 
the disintegration of biofilms depends on its ability chelator of iron, essential for bacterial 
growth, and stability of the links necessary for the extracellular matrix biofilms. Their use 
encourages the release of planktonic cells rather than their aggregation and biofilm 
(Castrillón 2010, Rodríguez-Franco et al., 2005). 
Endogenous production of enzymes allows degradation of exopolysaccharides of the 
biofilm to achieve dispersion of microorganisms for the generation of a new colony once the 
biofilm is mature and begin a new cycle of development, this allows us to propose the use of 
different enzymes for removal, however, due to the heterogeneity of extracellular 
polysaccharide, it is necessary to use a mixture enzymes for degradation. Among the most 
commonly used are dispersin D alginase, phage depolimerase, proteases, glycosidases: 
pectinase arabanase, cellulase, hemicellulase, beta-glucanase, xylanase, glucose oxidase and 
lactoperoxidase (Johansen et al., 1997, White, 2006, Kaplan et al., 2004). 
A different approach for the treatment of biofilms is the use of bacteriophages, viruses that 
are specific for the bacteria to replicate inside and kill them. It has been demonstrating its 
effectiveness with the use of bacteriophage T4, which can infect and replicate in Escherichia 
coli breaking up the morphology of the biofilm and killing the bacteria, or in the case of 
phage 456 on S. epidermidis. (Curtin & Donlan, 2006). A bacteriophage expressing enzymes 
that degrade the biofilm matrix has been designed and simultaneously attack the bacterial 
cells of Escherichia coli. This design eliminates the need to express, purify and deliver large 
doses of enzymes to specific sites of infection that impede access by the presence of the 
extracellular matrix (Lu & Collins, 2007). 
Pretreatment of catheters with hydrogel with a hydrolyzate of bacteriophage P. aeruginosa 
M4 reached lower cell density in biofilms after bacterial inoculation suggesting its potential 
use to prevent biofilm formation (Fu et al., 2010). 
8. Conclusions and perspectives 
The organization of the microorganisms to grow as a biofilm has been shown to have their 
own intrinsic mechanisms of resistance differ from those described stop the growth of 
microorganisms in free form. Therefore, these strategies should be considered resistance to 
explain therapeutic failure in the treatment of patients for whom laboratory results provide 
suitable sensitivity patterns. 
Growth as a biofilm is a risk factor for the spread of resistance to antibiotics and biocides as 
a long-term treatment with a microorganism determines their survival by developing a 
biofilm phenotype. 
Therapy in the future against biofilm-related infections should be considered as a priority to 
have standardized methods of diagnosis (still non-existent at the routine level) to determine 
differential management strategies of these infections. 
As biofilms are heterogeneous in nature, antibiotics are useful to control those who are 
active in cells with low metabolic activity or non-actively growing cells so requires the 
search for new antibiotics that fit this profile. 
The main strategy for controlling these infections is the use of agents that prevent biofilm 
formation as (quorum sensing inhibitors, inhibitors of synthesis of exopolysaccharides or 
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material handling to prevent sticking) and its growth has been kept as planktonic cells to be 
susceptible to the action of antibiotics and host immune system. Other possible control 
strategies for mature biofilm consisting of dispersal of the organism by specific enzymes 
responsible or bacteriophage that allow differential lysis. 
In conclusion, biofilm growth as a major advantage for microorganisms because of the 
variety of strategies developed by them not only to ensure their survival in hostile 
environments but to evade the antibiotics, so knowledge of the process and the mediators 
involved will allow us to direct them to our benefit. 
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